PDF(Pubmed)
Abstract：
UNASSIGNED: The importance of primary care physicians (PCPs) in managing metabolic dysfunction-associated steatotic liver disease (MASLD) has increased. This study aimed to assess the effectiveness of an online educational program on MASLD among physicians.
UNASSIGNED: In total, 869 physicians (72 physicians at referral centers and 797 PCPs) participated in this study. They completed an initial survey regarding their clinical practices for patients with MASLD, followed by a second online survey 8 weeks after receiving a series of seven weekly sets of educational materials on MASLD.
UNASSIGNED: In the baseline survey, most PCPs did not routinely evaluate the stage of hepatic fibrosis in MASLD; they typically initiated assessments based on elevated liver enzyme levels. Only a limited number of PCPs used vibration-controlled transient elastography. The main hurdles in managing MASLD were \"the absence of a fee for patient education\" for PCPs and \"short consultation time\" for referral-center physicians. In the follow-up survey, the percentage of liver fibrosis assessments using noninvasive tests increased from 7.0 to 11.2%. Additionally, evaluations for cardiovascular disease increased from 3.9 to 8.2%, and the risk of ischemic stroke increased from 13.7 to 16.9%. The percentage of immediate referrals of patients to specialists after an MASLD diagnosis decreased from 15.4 to 12.3%.
UNASSIGNED: The discrepancies in management strategies and viewpoints regarding MASLD between PCPs and referral-center physicians can hinder efforts to mitigate the disease burden. Increasing awareness among PCPs regarding MASLD through a 7-week education program led to a reduction in unnecessary referral rates and an increase in cardiovascular evaluations.
UNASSIGNED: In total, 869 physicians (72 physicians at referral centers and 797 PCPs) participated in this study. They completed an initial survey regarding their clinical practices for patients with MASLD, followed by a second online survey 8 weeks after receiving a series of seven weekly sets of educational materials on MASLD.
UNASSIGNED: In the baseline survey, most PCPs did not routinely evaluate the stage of hepatic fibrosis in MASLD; they typically initiated assessments based on elevated liver enzyme levels. Only a limited number of PCPs used vibration-controlled transient elastography. The main hurdles in managing MASLD were \"the absence of a fee for patient education\" for PCPs and \"short consultation time\" for referral-center physicians. In the follow-up survey, the percentage of liver fibrosis assessments using noninvasive tests increased from 7.0 to 11.2%. Additionally, evaluations for cardiovascular disease increased from 3.9 to 8.2%, and the risk of ischemic stroke increased from 13.7 to 16.9%. The percentage of immediate referrals of patients to specialists after an MASLD diagnosis decreased from 15.4 to 12.3%.
UNASSIGNED: The discrepancies in management strategies and viewpoints regarding MASLD between PCPs and referral-center physicians can hinder efforts to mitigate the disease burden. Increasing awareness among PCPs regarding MASLD through a 7-week education program led to a reduction in unnecessary referral rates and an increase in cardiovascular evaluations.
摘要：
■初级保健医师（PCP）在管理代谢功能障碍相关的脂肪变性肝病（MASLD）中的重要性增加。这项研究旨在评估医生中MASLD在线教育计划的有效性。
■总共，869名医生（72名转诊中心的医生和797名PCP）参与了这项研究。他们完成了一项关于他们对MASLD患者的临床实践的初步调查，在收到一系列关于MASLD的每周七套教育材料8周后，进行了第二次在线调查。
■在基线调查中，大多数PCP未常规评估MASLD中肝纤维化的分期;它们通常基于升高的肝酶水平开始评估.只有有限数量的PCP使用振动控制的瞬态弹性成像。管理MASLD的主要障碍是PCP的“患者教育费用不足”和转诊中心医师的“咨询时间短”。在后续调查中,使用非侵入性试验进行肝纤维化评估的百分比从7.0增加到11.2%.此外,对心血管疾病的评估从3.9%增加到8.2%，缺血性卒中的风险从13.7%增加到16.9%。MASLD诊断后，患者立即转诊给专家的百分比从15.4％降至12.3％。
PCP与转诊中心医师之间有关MASLD的管理策略和观点的差异可能会阻碍减轻疾病负担的努力。通过为期7周的教育计划，提高PCP对MASLD的认识导致不必要的转诊率降低和心血管评估增加。
■总共，869名医生（72名转诊中心的医生和797名PCP）参与了这项研究。他们完成了一项关于他们对MASLD患者的临床实践的初步调查，在收到一系列关于MASLD的每周七套教育材料8周后，进行了第二次在线调查。
■在基线调查中，大多数PCP未常规评估MASLD中肝纤维化的分期;它们通常基于升高的肝酶水平开始评估.只有有限数量的PCP使用振动控制的瞬态弹性成像。管理MASLD的主要障碍是PCP的“患者教育费用不足”和转诊中心医师的“咨询时间短”。在后续调查中,使用非侵入性试验进行肝纤维化评估的百分比从7.0增加到11.2%.此外,对心血管疾病的评估从3.9%增加到8.2%，缺血性卒中的风险从13.7%增加到16.9%。MASLD诊断后，患者立即转诊给专家的百分比从15.4％降至12.3％。
PCP与转诊中心医师之间有关MASLD的管理策略和观点的差异可能会阻碍减轻疾病负担的努力。通过为期7周的教育计划，提高PCP对MASLD的认识导致不必要的转诊率降低和心血管评估增加。
